Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile
Neuroendocrine Cancer Foundation

@ncfcancer

The Neuroendocrine Cancer Foundation (previously known as LACNETS) provides a community of support & education for those with neuroendocrine cancer.

ID: 111212291

linkhttps://www.ncf.net calendar_today04-02-2010 04:30:12

3,3K Tweet

1,1K Followers

425 Following

Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

#enets2025 - Jaume Capdevila presents the much anticipated results of ITM’s COMPETE study, the first prospective, randomized phase 3 study comparing PRRT with an active treatment (everolimus). Positive results & good tolerability suggest potential for 1L or 2L treatment GEPNETS

#enets2025 - <a href="/Ja_Capdevila/">Jaume Capdevila</a> presents the much anticipated results of ITM’s COMPETE study, the first prospective, randomized phase 3 study comparing PRRT with an active treatment (everolimus). Positive results &amp; good tolerability suggest potential for 1L or 2L treatment GEPNETS
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

#enets2025 ENETS-INCA joint session Thor Halfdanarson on Meaningful involvement of pts in NEN research Meredith Cummins NeuroEndocrine Cancer Australia on pts partnering 🌎 Timon Vandamme on aligning researcher & pt priorities Simron Singh on improving global research 🔑Essential to partner w advocates

#enets2025 ENETS-INCA joint session
<a href="/OncoThor/">Thor Halfdanarson</a> on Meaningful involvement of pts in NEN research 

Meredith Cummins <a href="/NECancerAus/">NeuroEndocrine Cancer Australia</a> on pts partnering 🌎  

<a href="/TimonV/">Timon Vandamme</a> on aligning researcher &amp; pt priorities 

Simron Singh on improving global research

🔑Essential to partner w advocates
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

#ENETS2025 Fantastic ENETS-NANETS joint session on future perspectives & opportunities for global development in NENs. 🔑Many exciting advances & promising approaches 🔑Need thoughtful, multiD approach for personalized treatment considering precision oncology & risk-adaptation

#ENETS2025 Fantastic ENETS-NANETS joint session on future perspectives &amp; opportunities for global development in NENs.  
🔑Many exciting advances &amp; promising approaches 
🔑Need thoughtful, multiD approach for personalized treatment considering precision oncology &amp; risk-adaptation
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

#ENETS2025 - Attention industry & researchers considering global trials: consider opening sites in Latin America to increase diversity and improve access to treatments. Please meet Dra Monica Meneses Mónica Meneses from @INCMNSZ in Mexico City ENETS NANETS CarcinoidCancer CCF

#ENETS2025 - Attention industry &amp; researchers considering global trials: consider opening sites in Latin America to increase diversity and improve access to treatments. 
Please meet Dra Monica Meneses <a href="/MoniquMeneses/">Mónica Meneses</a> from @INCMNSZ in Mexico City <a href="/ENETS_ORG/">ENETS</a> 
<a href="/NANETS1/">NANETS</a> <a href="/CarcinoidNETs/">CarcinoidCancer CCF</a>
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

In case you missed it, "PRRT Nurse's Perspective: What to Expect with PRRT" is now available. 📷 youtu.be/Ton887q1R6s #ncfcancer #NeuroendocrineCancer #NETcancer CarcinoidCancer CCF

CarcinoidCancer CCF (@carcinoidnets) 's Twitter Profile Photo

Join us this Thursday, March 20th, at 12PM ET, for the next episode of "Luncheon with the Experts!" Our featured guest will be NET expert, Delphine L. Chen, MD !

Join us this Thursday, March 20th, at 12PM ET, for the next episode of "Luncheon with the Experts!" 

Our featured guest will be NET expert, Delphine L. Chen, MD !
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

➡️Register at ncf.net/events/apr2025 Learn from internationally-renowned neuroendocrine cancer expert Dr. Edward Wolin in a discussion on the latest in neuroendocrine tumor treatments and understanding how to sequence them. Dr. Wolin has pioneered many of the NET treatments,

➡️Register at ncf.net/events/apr2025

Learn from internationally-renowned neuroendocrine cancer expert Dr. Edward Wolin in a discussion on the latest in neuroendocrine tumor treatments and understanding how to sequence them. Dr. Wolin has pioneered many of the NET treatments,
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

Breaking news: The U.S. FDA approved Cabozantinib (Exelixis) for patients 12 and older with previously treated, advanced #NeuroendocrineTumors. For details, please visit bit.ly/3DTtTPu. Watch our interviews with Dr. Jennifer Chan on the #CABINET results:

Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

Last weekend, NCF hosted a Regional NET Patient Educational Event in Tucson. 75 NET community members gathered for an afternoon dedicated to learning, connection and hope. Read more at ncf.net/post/a-day-of-…

Last weekend, NCF hosted a Regional NET Patient Educational Event in Tucson. 75 NET community members gathered for an afternoon dedicated to learning, connection and hope.

Read more at ncf.net/post/a-day-of-…
NANETS (@nanets1) 's Twitter Profile Photo

Help shape the future of NET care! Take a few minutes to complete the NETPact patient survey and share your experiences. Your input is vital in driving advocacy efforts and improving support for the NET community. 🔗 loom.ly/0LZed14 #PatientSurvey #NETPact #NANETS

Help shape the future of NET care! Take a few minutes to complete the NETPact patient survey and share your experiences. Your input is vital in driving advocacy efforts and improving support for the NET community. 

🔗 loom.ly/0LZed14

#PatientSurvey #NETPact #NANETS
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

📷📷 Register at ncf.net/events/apr29 Learn from Cardiologist and Congenital Heart Disease Specialist Dr. Prashanth Venkatesh from Cedars-Sinai Smidt Heart Institute in a virtual educational event on carcinoid heart disease. Dr. Venkatesh demystifies the topic and shares the

📷📷 Register at ncf.net/events/apr29

Learn from Cardiologist and Congenital Heart Disease Specialist Dr. Prashanth Venkatesh from Cedars-Sinai Smidt Heart Institute in a virtual educational event on carcinoid heart disease. Dr. Venkatesh demystifies the topic and shares the
CarcinoidCancer CCF (@carcinoidnets) 's Twitter Profile Photo

Join us this Thursday, May 1st, at 12PM ET, for the next episode of "Luncheon with the Experts!" Our featured guest will be NET expert, Mintallah (Menna) Haider, MD!

Join us this Thursday, May 1st, at 12PM ET, for the next episode of "Luncheon with the Experts!" Our featured guest will be NET expert, Mintallah (Menna) Haider, MD!
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

Tune in today at 3 PM Pacific to watch "Evolving Management of Carcinoid Heart Syndrome: What We Know & What's New" with Dr. Venkatesh. 📺📌 ncf.net/events/apr29 #NETcancer #ncfcancer #LACNETS #NeuroendocrineCancer #NeuroendocrineTumor CarcinoidCancer CCF Healing NET NANETS

Tune in today at 3 PM Pacific to watch "Evolving Management of Carcinoid Heart Syndrome: What We Know &amp; What's New" with Dr. Venkatesh.
📺📌 ncf.net/events/apr29

#NETcancer #ncfcancer #LACNETS #NeuroendocrineCancer #NeuroendocrineTumor

<a href="/CarcinoidNETs/">CarcinoidCancer CCF</a> <a href="/HealingNET1/">Healing NET</a> <a href="/NANETS1/">NANETS</a>
Neuroendocrine Cancer Foundation (@ncfcancer) 's Twitter Profile Photo

Register by May 10th! ncf.net/events/califor… Join us in Santa Monica, CA, on May 17th for a patient conference. - Hear four presentations from neuroendocrine cancer experts. - Engage in two Q&A sessions. - Listen to a patient's story. - Learn about liver-directed therapy,

Register by May 10th! ncf.net/events/califor…

Join us in Santa Monica, CA, on May 17th for a patient conference.

- Hear four presentations from neuroendocrine cancer experts.
- Engage in two Q&amp;A sessions.
- Listen to a patient's story.
- Learn about liver-directed therapy,